Insights

Global Expansion Lumenis has a solid global footprint with sales in over 100 countries and offices on four continents, indicating strong cross-border sales opportunities and potential collaborations in diverse markets.

Recent Innovations Launches like OptiLIFT in Canada and the next generation triLIFT 2.0 Muscle Stimulation platform show a pipeline of cutting-edge energy-based treatments that can drive upsell opportunities with clinics seeking the latest devices.

Awarded Technology Recognition such as the Best New Dermatology Technology Solution at the MedTech Breakthrough Awards enhances credibility with prospective customers and can be leveraged in sales pitches to justify premium positioning.

Clinical Data Momentum Active participation in high-profile conferences (ASLMS) and published clinical data demonstrate evidence-based results, supporting conversations with medical directors and procurement teams about efficacy and ROI.

Diverse Treatment Portfolio A broad offering across aesthetic, skin, body, and eye care, including Stellar M22 and triLIFT platforms, provides multiple cross-sell and bundle opportunities for clinics looking to expand service lines and improve chair time utilization.

Lumenis Tech Stack

Lumenis uses 8 technology products and services including MATLAB, HubSpot Analytics, jQuery CDN, and more. Explore Lumenis's tech stack below.

  • MATLAB
    Advanced Analytics And Data Science
  • HubSpot Analytics
    Analytics
  • jQuery CDN
    Content Delivery Network
  • Oracle
    Enterprise
  • Underscore.js
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • reCAPTCHA
    Security
  • Google Analytics
    Web Analytics

Media & News

Lumenis's Email Address Formats

Lumenis uses at least 1 format(s):
Lumenis Email FormatsExamplePercentage
FLast@lumenis.comJDoe@lumenis.com
50%
First.Last@lumenis.comJohn.Doe@lumenis.com
46%
FirstLast@lumenis.comJohnDoe@lumenis.com
3%
First-Last@lumenis.comJohn-Doe@lumenis.com
1%

Frequently Asked Questions

What is Lumenis's phone number?

Minus sign iconPlus sign icon
You can contact Lumenis's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Lumenis's stock symbol?

Minus sign iconPlus sign icon
Lumenis is a publicly traded company; the company's stock symbol is LMNS.

What is Lumenis's official website and social media links?

Minus sign iconPlus sign icon
Lumenis's official website is lumenis.com and has social profiles on LinkedInCrunchbase.

What is Lumenis's NAICS code?

Minus sign iconPlus sign icon
Lumenis's NAICS code is 33911 - Medical Equipment and Supplies Manufacturing.

How many employees does Lumenis have currently?

Minus sign iconPlus sign icon
As of July 2026, Lumenis has approximately 1.4K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: T. O.Ceo Executive Assistant & Employee Welfare Manager: A. P.Ceo: S. M.. Explore Lumenis's employee directory with LeadIQ.

What industry does Lumenis belong to?

Minus sign iconPlus sign icon
Lumenis operates in the Medical Device industry.

What technology does Lumenis use?

Minus sign iconPlus sign icon
Lumenis's tech stack includes MATLABHubSpot AnalyticsjQuery CDNOracleUnderscore.jsHubSpotreCAPTCHAGoogle Analytics.

What is Lumenis's email format?

Minus sign iconPlus sign icon
Lumenis's email format typically follows the pattern of FLast@lumenis.com. Find more Lumenis email formats with LeadIQ.

How much funding has Lumenis raised to date?

Minus sign iconPlus sign icon
As of July 2026, Lumenis has raised $135M in funding. The last funding round occurred on Jul 02, 2009 for $15M.

When was Lumenis founded?

Minus sign iconPlus sign icon
Lumenis was founded in 1966.
Lumenis logo

Lumenis

Medical DeviceCalifornia, United States1001-5000 Employees

Lumenis designs and sells energy-based medical devices used for skin, body, and eye care, enabling a range of treatments across dermatology, aesthetics, and ophthalmology. Its technologies are aimed at addressing conditions that were difficult to treat and expanding the treatment options available to clinicians. The company serves medical professionals and clinics worldwide, delivering solutions intended to improve both therapeutic outcomes and cosmetic results.

Reflecting a global footprint, Lumenis operates in developed and emerging markets with sales in more than 100 countries and offices across multiple continents. It is based in San Jose, California, and maintains a sizable international team. In 2026, the company announced the commercial launch of triLIFT 2.0, a next-generation platform for facial and body muscle stimulation.

Section iconCompany Overview

Phone number
Stock Symbol
LMNS
NAICS Code
33911 - Medical Equipment and Supplies Manufacturing
Founded
1966
Employees
1001-5000

Section iconFunding & Financials

  • $135M

    Lumenis has raised a total of $135M of funding over 2 rounds. Their latest funding round was raised on Jul 02, 2009 in the amount of $15Mas a series_unknown.

  • $1B$10B

    Lumenis's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $135M

    Lumenis has raised a total of $135M of funding over 2 rounds. Their latest funding round was raised on Jul 02, 2009 in the amount of $15Mas a series_unknown.

  • $1B$10B

    Lumenis's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.